Machine learning could transform early cancer detection in primary care

A new editorial paper was published in Oncoscience (Volume 10) on June 9, 2023, entitled, "Transforming early cancer detection in primary care: harnessing the power of machine learning."

Cancer remains a significant global health burden, and early detection plays a crucial role in improving patient outcomes. Primary care settings serve as frontline gatekeepers, providing an opportunity for early detection through symptom assessment and targeted screening. However, detecting early-stage cancer and identifying individuals at high risk can be challenging due to the complexity and subtlety of symptoms.

The challenging nature of early detection is revealed by diagnostic errors in primary care, with cancer being one of the most frequently missed or delayed diagnoses. In recent years, the emergence of machine learning (ML) techniques has shown promise in revolutionizing early detection efforts. In this new editorial, researchers Elinor Nemlander, Marcela Ewing, Axel C. Carlsson, and Andreas Rosenblad from Karolinska Institutet and the Academic Primary Health Care Centre at Region Stockholm explore the potential of ML in enhancing early cancer detection in primary care.

"ML has the potential to transform early cancer detection in primary care by leveraging extensive patient data and improving risk stratification and pre-diagnostic accuracy, hopefully saving lives. However, responsible and equitable implementation of ML models requires careful attention to ethical considerations, collaboration, and validation across diverse populations."

Source:
Journal reference:

Nemlander, E., et al. (2023) Transforming early cancer detection in primary care: harnessing the power of machine learning. Oncoscience. doi.org/10.18632/oncoscience.578.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows AI can predict prognosis in triple-negative breast cancer